-
Founded in:
1999-01-22 -
Country:
China -
Address:
No. 31, Songhuahu Street, Shenyang Economic and Technological Development Zone -
Tax NO.:
912101064107084581 -
Registered Funds:
8.82 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium bisulfite of dodecanoyl acetaldehyde |
It has obvious inhibitory effect on Pneumococcus, Salmonella typhi, Staphylococcus aureus, Escherichia coli and Sporothrix; it can improve the body's immunity, enhance the phagocytic function of the patient's leukocytes, increase the level of serum properdin, and improve the body's nonspecific immunity.
More
It has obvious inhibitory effect on Pneumococcus, Salmonella typhi, Staphylococcus aureus, Escherichia coli and Sporothrix; it can improve the body's immunity, enhance the phagocytic function of the patient's leukocytes, increase the level of serum properdin, and improve the body's nonspecific immunity. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| L-GLUTAMIC ACID MONOPOTASSIUM SALT |
When liver function is severely damaged, ammonia metabolism in the body is disordered, leading to hepatic coma. After intravenous infusion, this product can combine with excess ammonia in the blood to form non-toxic glutamine, which dissociates ammonia through the action of glutaminase in the kidneys and is excreted in the urine, thus alleviating the symptoms of hepatic coma. This product also participates in brain protein metabolism and sugar metabolism, promotes the oxidation process, and improves the function of the central nervous system.
More
When liver function is severely damaged, ammonia metabolism in the body is disordered, leading to hepatic coma. After intravenous infusion, this product can combine with excess ammonia in the blood to form non-toxic glutamine, which dissociates ammonia through the action of glutaminase in the kidneys and is excreted in the urine, thus alleviating the symptoms of hepatic coma. This product also participates in brain protein metabolism and sugar metabolism, promotes the oxidation process, and improves the function of the central nervous system. |
19473-49-5 | 0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Potassium L-aspartate |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
14007-45-5 | 11 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| L-Arginine hydrochloride |
This product is an amino acid drug. It can participate in the ornithine cycle in the human body, promote the formation of urea, and convert ammonia produced in the human body into non-toxic urea through the ornithine cycle and be excreted from the urine, thereby reducing blood ammonia concentration.
More
This product is an amino acid drug. It can participate in the ornithine cycle in the human body, promote the formation of urea, and convert ammonia produced in the human body into non-toxic urea through the ornithine cycle and be excreted from the urine, thereby reducing blood ammonia concentration. |
1119-34-2 | 25 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| L-Arginine hydrochloride |
This product is an amino acid drug. It can participate in the ornithine cycle in the human body, promote the formation of urea, and convert ammonia produced in the human body into non-toxic urea through the ornithine cycle and be excreted from the urine, thereby reducing blood ammonia concentration.
More
This product is an amino acid drug. It can participate in the ornithine cycle in the human body, promote the formation of urea, and convert ammonia produced in the human body into non-toxic urea through the ornithine cycle and be excreted from the urine, thereby reducing blood ammonia concentration. |
1119-34-2 | 25 |